Please Wait

Applying Filters...

All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

pipeline-prospector-insert

X

List of Excipients/Inactive Ingredients Finished Dosage Forms (Formulations)

DRUG DEVELOPMENT ASSISTANT

FOR SOLUTION;OPHTHALMIC - 0.13%

INJECTABLE;INJECTION - EQ 50MG IRON/ML

INJECTABLE;INJECTION - EQ 0.004MG CHROMIUM/ML

SOLUTION/DROPS;OPHTHALMIC - EQ 0.5% BASE

INJECTABLE;INJECTION - 10MG/ML

INJECTABLE;INJECTION - 1GM/100ML

INJECTABLE;INJECTION - 2GM/100ML

SOLUTION;TOPICAL - 0.50%

SUSPENSION/DROPS;OPHTHALMIC - EQ 0.25% BASE

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG

TABLET;ORAL - 5MG

TABLET;ORAL - 2.5MG;1GM

TABLET;ORAL - 2.5MG;500MG

TABLET;ORAL - 2.5MG;850MG

TABLET;ORAL - 200MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 5MG

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 5MG BASE

LIQUID;ORAL - 1.1GM/ML

TABLET;ORAL - EQ 2.08MG BASE

GEL;TOPICAL - 0.50%

SOLUTION;INTRAVENOUS - EQ 400MG BASE/250ML (EQ 1.6MG BASE/ML)

CAPSULE;ORAL - 20MG

SOLUTION;INTRAVENOUS - 2.5GM/250ML (10MG/ML)

SOLUTION;INTRAVENOUS - 2GM/100ML (20MG/ML)

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 17MG BASE

POWDER;INTRAVENOUS - 1MG/VIAL

TABLET, EXTENDED RELEASE;ORAL - 2.5MG;1GM

TABLET, EXTENDED RELEASE;ORAL - 5MG;1GM

TABLET, EXTENDED RELEASE;ORAL - EQ 11MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 22MG BASE

CAPSULE;ORAL - 40MG

CAPSULE;ORAL - 80MG

TABLET, FOR SUSPENSION;ORAL - 32MG

TABLET, CHEWABLE;ORAL - 800MG;10MG;165MG

TABLET;ORAL - 15MG

CAPSULE;ORAL - EQ 34MG BASE

TABLET;ORAL - EQ 400MG BASE

TABLET;ORAL - 180MG

TABLET;ORAL - 180MG;10MG

TABLET, EXTENDED RELEASE;ORAL - 10MG;5MG;1GM

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;2.5MG;1GM

TABLET, EXTENDED RELEASE;ORAL - 25MG;5MG;1GM

TABLET, EXTENDED RELEASE;ORAL - 5MG;2.5MG;1GM

SOLUTION;INTRAVENOUS - 400MG/250ML (1.6MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

TABLET;ORAL - 125MG

TABLET;ORAL - 62.5MG

FOR SUSPENSION;ORAL - 40MG/ML

INJECTABLE;INTRAMUSCULAR - 50MG/ML

TABLET;ORAL - 10MG

TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

SOLUTION/DROPS;OPHTHALMIC - EQ 0.5% BASE

$PACKAGE LABEL â€“ Prasugrel 10 mg 30 Tablets\n$

TABLET;ORAL - EQ 10MG BASE

$PACKAGE LABEL â€“ Prasugrel 5 mg 30 Tablets\n$

TABLET;ORAL - EQ 5MG BASE

SUSPENSION/DROPS;OPHTHALMIC - EQ 0.6% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 0.5% BASE

$PRINCIPAL DISPLAY PANEL\n Gilenya\n 0.25 mg \n 7 Capsules$

CAPSULE;ORAL - EQ 0.25MG BASE

$PRINCIPAL DISPLAY PANEL\n Gilenya\n 0.5 mg \n 30 Capsules$

CAPSULE;ORAL - EQ 0.5MG BASE

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

X

Contact us
to update this info

Market Place

Home

Menu

Post Enquiry

Market Place

Search